|
HERC1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.051800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.833200E-01 |
| Normal-vs-Stage2 |
9.361000E-01 |
| Normal-vs-Stage3 |
2.042700E-03 |
| Normal-vs-Stage4 |
5.620500E-02 |
| Stage1-vs-Stage2 |
6.545200E-01 |
| Stage1-vs-Stage3 |
3.93490000000218E-05 |
| Stage1-vs-Stage4 |
1.062140E-02 |
| Stage2-vs-Stage3 |
4.072300E-02 |
| Stage2-vs-Stage4 |
1.487220E-01 |
| Stage3-vs-Stage4 |
8.448600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.334000E-02 |
| Normal-vs-AfricanAmerican |
6.468300E-02 |
| Normal-vs-Asian |
4.843200E-01 |
| Caucasian-vs-AfricanAmerican |
7.242100E-03 |
| Caucasian-vs-Asian |
1.806210E-01 |
| AfricanAmerican-vs-Asian |
8.626600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.846300E-02 |
| Normal-vs-Female |
8.222000E-01 |
| Male-vs-Female |
4.812300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.428200E-01 |
| Normal-vs-Age(41-60Yrs) |
7.542000E-01 |
| Normal-vs-Age(61-80Yrs) |
5.189800E-02 |
| Normal-vs-Age(81-100Yrs) |
1.086300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.637400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.121400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.695800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.836260E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.170430E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.951970E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.099020E-03 |
| Normal-vs-Grade 2 |
6.407200E-01 |
| Normal-vs-Grade 3 |
1.088590E-01 |
| Normal-vs-Grade 4 |
9.68719999999701E-05 |
| Grade 1-vs-Grade 2 |
2.151500E-02 |
| Grade 1-vs-Grade 3 |
3.202200E-03 |
| Grade 1-vs-Grade 4 |
4.93479999974511E-07 |
| Grade 2-vs-Grade 3 |
2.554300E-02 |
| Grade 2-vs-Grade 4 |
1.88199999995309E-06 |
| Grade 3-vs-Grade 4 |
9.738200E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.282200E-01 |
| Normal-vs-ccB subtype |
1.532160E-01 |
| ccA subtype-vs-ccB subtype |
9.285700E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.860400E-01 |
| Normal-vs-N1 |
4.199300E-03 |
| N0-vs-N1 |
1.673920E-02 |
|
|
